TGA issues guidance on post-expiry date usage of shortage-impacted treatment The Therapeutic Goods Administration says tocilizumab vials continue to be stable for a further six months past their labelled expiry date. This follows the medicine being added to the list of products interchangeable at a pharmacy level. Roche, the manufacturer of tocilizumab (Actemra) has confirmed
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.